Physician profile
John G Beasley
NPI 1962416073
$7,614.20
in general payments reported to CMS, 2019-2025
41 companies · $711 in 2025
The $711 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,324 · 2020: $469 · 2021: $390 · 2022: $635 · 2023: $1,029 · 2024: $1,056 · 2025: $711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,795.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $2,531.15 | 2019-2020 | |
| Medtronic, INC. | $821.41 | 2021-2025 | Interstim |
| Abbvie INC. | $700.94 | 2019-2025 | Botox, Avycaz |
| Coloplast Corp | $612.90 | 2019-2025 | Speedicath |
| Teleflex LLC | $461.47 | 2021-2024 | Urolift |
| Boston Scientific Corporation | $304.53 | 2019 | |
| Sumitomo Pharma America, INC. | $288.67 | 2023-2025 | Gemtesa, Orgovyx |
| Procept Biorobotics Corporation | $210.92 | 2019-2025 | Aquabeam System |
| Astellas Pharma US INC | $169.49 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $137.53 | 2019-2020 | |
| Allergan, INC. | $134.71 | 2019-2020 | |
| Photocure INC | $89.64 | 2019 | |
| Cook Medical LLC | $84.98 | 2024 | Litho 150 |
| Olympus America INC. | $81.17 | 2024-2025 | Itind System |
| Janssen Biotech, INC. | $80.91 | 2019-2024 | Erleada |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Beasley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.